시장보고서
상품코드
1713246

경장영양 시장 규모와 예측(2021-2031년), 세계 및 지역 점유율, 동향, 성장 기회 분석 : 제품 유형별, 용도별, 연령층별, 유통 채널별, 지역별

Enteral Nutrition Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, Age Group, Distribution Channel, and Geography

발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 281 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

경장영양 시장은 2024년에 105억 8,000만 달러로 평가되었으며 2031년까지 173억 3,000만 달러에 달할 것으로 예상되며, 2025-2031년 사이 7.3%의 CAGR을 기록할 것으로 예상됩니다. 위장 질환의 유병률 증가, 영양실조 및 조산 사례의 증가는 경장영양 시장 규모 확대에 기여하고 있습니다. 그러나 영양 공급 시스템에 따른 합병증은 장내 영양 시장의 성장을 저해하고 있습니다. 또한, 식물 기반 영양 제품의 개발은 향후 몇 년 동안 새로운 장내 영양 시장 동향을 가져올 것으로 예상됩니다.

아시아태평양은 전 세계 경장영양제 시장에서 가장 빠른 성장률을 보이고 있습니다. 아시아태평양의 경장영양식 시장은 중국, 일본, 인도, 한국, 호주, 기타 아시아태평양으로 구분됩니다. 이 시장의 성장을 주도하고 있는 것은 만성질환의 유병률 증가와 이 지역 전체에서 시장 진입 기업의 존재감이 증가하고 있으며, 경장영양 제품 제조가 가장 활발하게 이루어지고 있다는 것을 알 수 있습니다. 또한, 정부의 적극적인 노력과 영양 분야의 연구가 시장 성장을 촉진하고 있습니다. 호주, 인도, 한국 등의 국가는 의료 부문의 발전이 증가함에 따라 다양한 성장 기회를 보일 것으로 추정됩니다. 또한, 이들 국가의 정부는 경장 및 비경구 영양 공급을 위한 노력을 강화하고 있습니다.

수익 측면에서는 중국이 2024년 아시아태평양 시장을 장악했습니다. 예측 기간 동안 세계 시장에서 중국의 우위는 계속될 것으로 보입니다.

중국에서는 노인 인구가 크게 증가하고 있습니다. 급속한 고령화로 인해 만성질환의 유병률이 증가하고 영양 지원이 필요한데, 2020년 인구 조사 데이터에 따르면 약 2억 6,400만 명이 60세 이상 연령층으로 중국 인구의 약 19%를 차지합니다. 중국 국가고령화위원회(CNCA)는 2050년까지 노인 인구가 약 4억 8,700만 명에 달할 것으로 예측하고 있습니다. 노인 인구의 증가에 따른 신경 질환의 유병률 증가는 중국 내 경장영양 채택을 촉진하고 있습니다. 뇌졸중은 중국 노인의 주요 사망 원인으로, 엘스비어(Elsevier)에 게재된 연구에 따르면 2020년 중국에서는 1,780만 건의 뇌졸중, 340만 건의 신규 뇌졸중, 230만 건의 뇌졸중 관련 사망이 보고되었습니다. 뇌졸중은 급성 연하장애의 가장 흔한 원인으로 영양실조를 유발하고 환자의 삶의 질에 영향을 미칠 수 있습니다. 중국에서는 중증 뇌졸중 환자의 영양 개선 전략으로 경관영양이 시행되고 있습니다.

WHO에 따르면 2022년 중국에서는 480만 명의 암 환자가 새로 발생하고 250만 명이 암으로 사망할 것으로 예상되며, 매분 7명 가까이 암 진단을 받고 4명이 암으로 사망할 것으로 예상됩니다. 매분 7명이 암 진단을 받고 4명이 암으로 목숨을 잃고 있습니다. 경장영양제의 사용은 화학요법을 받고 있는 암 환자에서 흔히 볼 수 있으며, 메스꺼움, 구내염, 위장장애로 인해 식사에 어려움을 겪는 경우가 많습니다.

장내 영양 시장 보고서 부문 분석

장내 영양 시장 분석 도출에 기여한 주요 부문은 제품 유형, 용도, 연령대, 유통 채널입니다.

제품 유형에 따라 경장영양 시장은 비위관, 비위관, 경장, 배송, 기타로 분류되며, 2024년 경장영양 시장은 비위관 부문이 가장 큰 점유율을 차지할 것으로 예상됩니다.

용도별로는 소화기 질환, 신장 질환, 간 질환, 종양학, 신경학, 기타로 분류되며, 2024년 경장영양제 시장은 소화기 질환 분야가 가장 큰 점유율을 차지할 것으로 예상됩니다.

연령대별로 장내 영양 시장은 성인과 소아로 나뉩니다. 성인 부문은 2024년 경장영양제 시장에서 가장 큰 점유율을 차지했습니다.

유통 채널에 따라 경장영양 시장은 병원 약국, 소매점, E-Commerce로 구분되며, 2024년 경장영양 시장은 병원 약국 부문이 가장 큰 점유율을 차지할 것으로 예상됩니다.

장내 영양 시장 경쟁 상황 및 주요 발전 상황

Nestle,Danone S.A.,Abbott Laboratories,FrieslandCampina,Fresenius SE and Co.KGaA,B. Braun SE,Dr. Company PLC, Fonterra Co-operative Group Limited, Kate Farms, Nutritional Medicinals, LLC 등이 경장영양제 시장에서 사업을 전개하는 주요 기업입니다.

국민보건서비스(NHS), 영국 비경구 및 경장영양협회, 세계보건기구(WHO), 미국 보건복지부, 질병통제예방센터, 영국영양사협회, 국가안전위원회 등은 경장영양 시장 보고서를 작성할 때 참고한 1차 및 2차 정보입니다.

목차

제1장 소개

제2장 주요 요약

  • 주요 인사이트

제3장 조사 방법

  • 2차 조사
  • 1차 조사
    • 가설 책정
    • 거시경제 요인 분석
    • 파운데이션 수치 개발
    • 데이터 삼각측량
    • 국가 레벨 데이터

제4장 경장영양 시장 상황

  • PEST 분석

제5장 경장영양 시장 - 주요 시장 역학

  • 경장영양 시장 - 주요 시장 역학
  • 시장 성장 촉진요인
    • 위장질환 유병률 증가
    • 영양 불량과 조산 케이스 증가
  • 시장 성장 억제요인
    • 영양 보급 시스템에 따른 합병증
  • 시장 기회
    • 시장 기업의 전략적 대처
  • 향후 동향
    • 특정 처방과 식물 기반 영양 제품
  • 성장 촉진요인과 억제요인의 영향

제6장 경장영양 시장 : 세계 시장 분석

  • 경장영양 시장 매출, 2021-2031년
  • 경장영양 시장 예측 분석

제7장 경장영양 시장 분석 - 제품 유형별

  • Nasogastric
  • Nasoenteral
  • Sipping
  • 기타

제8장 경장영양 시장 분석 - 용도별

  • 소화기질환
  • 신장질환
  • 간질환
  • 종양학
  • 신경학
  • 기타

제9장 경장영양 시장 분석 - 연령층별

  • 성인
  • 소아

제10장 경장영양 시장 분석 - 유통 채널별

  • 병원 약국
  • 소매점
  • E-Commerce

제11장 경장영양 시장 - 지역별 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 체코
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 아시아태평양의 기타 국가
  • 중동 및 아프리카
    • 사우디아라비아
    • 남아프리카공화국
    • 아랍에미리트
    • 기타 중동 및 아프리카
  • 중남미
    • 브라질
    • 아르헨티나
    • 기타 중남미

제12장 업계 상황

  • 경장영양 시장의 성장 전략
  • 유기적 성장 전략
  • 무기적 성장 전략

제13장 기업 개요

  • Nestle SA
  • Danone SA
  • Abbott Laboratories
  • Royal FrieslandCampina NV
  • Fresenius SE & Co KGaA
  • B Braun SE
  • Reckitt Benckiser Group Plc
  • Kate Farms Inc
  • Dr Schar AG
  • Fonterra Co-Operative Group Ltd
  • Arla Foods amba
  • Perrigo Co Plc
  • Charing Cross Scientific AS
  • Bexen Medical

제14장 부록

ksm 25.05.09

The Enteral Nutrition market was valued at US$ 10.58 billion in 2024 and is projected to reach US$ 17.33 billion by 2031; it is expected to register a CAGR of 7.3% during 2025-2031. Increasing prevalence of gastrointestinal diseases and the rising cases of malnutrition and premature births are contributing to the growing enteral nutrition market size. However, the complications associated with the feeding systems hampers the enteral nutrition market growth. Further, development of plant-based nutrition products is expected to bring in new enteral nutrition market trends in the coming years.

Asia-Pacific region to witness fastest growth rate in the global enteral nutrition market. The Asia Pacific enteral nutrition market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the market is driven by rising prevalence of chronic diseases and the growing presence of market players across the region, conferring the highest manufacturing of enteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth. Countries such as Australia, India, and South Korea are estimated to witness various growth opportunities due to the rising development in the healthcare sector. In addition, governments of these countries are increasing their efforts to provide enteral and parenteral nutrition.

In terms of revenue, China dominated the Asia Pacific market in 2024. It is expected to continue its dominance in the global market during the forecast period.

China has experienced a significant rise in the elderly population. Its rapidly aging demographic has led to an increased prevalence of chronic diseases, necessitating nutritional support. According to the 2020 census data, ~264 million were in the age group of 60 and above, and accounted for almost 19% of the Chinese population. The China National Committee on Aging (CNCA) projected that the geriatric population is expected to reach ~487 million by 2050. The increasing prevalence of neurological diseases with the growing elderly population fuels the adoption of enteral nutrition in China. Stroke is the primary cause of death among older people across the country. According to the study published in Elsevier, 17.8 million cases of stroke, 3.4 million new strokes, and 2.3 million stroke-related deaths were reported in the country in 2020. Stroke is the most common cause of acute dysphagia, which may cause malnutrition and impact the quality of life of patients. Tube feeding of critically ill stroke patients is implemented as a nutrition improvement strategy in China.

The increasing number of cancer cases in China also benefits the enteral nutrition market. According to the WHO, ~4.8 million new cancer cases and ~2.5 million deaths due to cancer were reported in China in 2022. Every minute, nearly seven individuals are diagnosed with cancer, and four succumb to the disease. The use of enteral feeding is common in cancer patients undergoing chemotherapy, who often experience difficulty eating due to nausea, mouth sores, or gastrointestinal disturbances..

Enteral Nutrition Market Report Segmentation Analysis

Key segments that contributed to the derivation of the enteral nutrition market analysis are product type, application, age group, and distribution channel.

Based on product type, the enteral nutrition market is categorized into nasogastric, nasoenteral, sipping, and other. The nasogastric segment held the largest share in the enteral nutrition market in 2024.

In terms of application, the enteral nutrition market is segmented into gastrointestinal disorders, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest share in the enteral nutrition market in 2024.

By age group, the enteral nutrition market is bifurcated into adult and pediatric. The adult segment held the largest share in the enteral nutrition market in 2024.

Based on distribution channel, the enteral nutrition market is segmented into hospital pharmacies, retail stores, and e-commerce. The hospital pharmacies segment held the largest share in the enteral nutrition market in 2024

Enteral Nutrition Market: Competitive Landscape and Key Developments

Nestle, Danone S.A., Abbott Laboratories, FrieslandCampina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schar AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, Nutritional Medicinals, LLC are among the key companies operating in the enteral nutrition market.

The National Health Service (NHS), British Association for Parenteral and Enteral Nutrition, World Health Organization, US Department of Health and Human Services, Centers for Disease Control and Prevention, British Dietic Association, and National Safety Council are among the primary and secondary sources referred to while preparing the Enteral Nutrition market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Enteral Nutrition Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Enteral Nutrition Market - Key Market Dynamics

  • 5.1 Enteral Nutrition Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Gastrointestinal Diseases
    • 5.2.2 Rising Cases of Malnutrition and Premature Births
  • 5.3 Market Restraints
    • 5.3.1 Complications Associated with the Feeding Systems
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Specific Formulations and Plant-Based Nutrition Products
  • 5.6 Impact of Drivers and Restraints:

6. Enteral Nutrition Market - Global Market Analysis

  • 6.1 Enteral Nutrition Market Revenue (US$ Million), 2021-2031
  • 6.2 Enteral Nutrition Market Forecast Analysis

7. Enteral Nutrition Market Analysis - by Product Type

  • 7.1 Nasogastric
    • 7.1.1 Overview
    • 7.1.2 Nasogastric: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Nasoenteral
    • 7.2.1 Overview
    • 7.2.2 Nasoenteral: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Sipping
    • 7.3.1 Overview
    • 7.3.2 Sipping: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

8. Enteral Nutrition Market Analysis - by Application

  • 8.1 Gastrointestinal Disorders
    • 8.1.1 Overview
    • 8.1.2 Gastrointestinal Disorders: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Renal Disease
    • 8.2.1 Overview
    • 8.2.2 Renal Disease: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Liver Disease
    • 8.3.1 Overview
    • 8.3.2 Liver Disease: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Oncology
    • 8.4.1 Overview
    • 8.4.2 Oncology: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

9. Enteral Nutrition Market Analysis - by Age Group

  • 9.1 Adult
    • 9.1.1 Overview
    • 9.1.2 Adult: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Pediatric
    • 9.2.1 Overview
    • 9.2.2 Pediatric: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

10. Enteral Nutrition Market Analysis - by Distribution Channel

  • 10.1 Hospital Pharmacies
    • 10.1.1 Overview
    • 10.1.2 Hospital Pharmacies: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Retail Stores
    • 10.2.1 Overview
    • 10.2.2 Retail Stores: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 E-commerce
    • 10.3.1 Overview
    • 10.3.2 E-commerce: Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

11. Enteral Nutrition Market - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Enteral Nutrition Market Overview
    • 11.1.2 North America: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
      • 11.1.2.1 North America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Product Type
        • 11.1.2.1.1 North America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Nasogastric
      • 11.1.2.2 North America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Application
      • 11.1.2.3 North America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Age Group
      • 11.1.2.4 North America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Distribution Channel
    • 11.1.3 North America: Enteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 11.1.3.1 United States: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.1.3.1.1 United States: Enteral Nutrition Market Breakdown, by Product Type
        • 11.1.3.1.1.1 United States: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.1.3.1.2 United States: Enteral Nutrition Market Breakdown, by Application
        • 11.1.3.1.3 United States: Enteral Nutrition Market Breakdown, by Age Group
        • 11.1.3.1.4 United States: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.1.3.2 Canada: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.1.3.2.1 Canada: Enteral Nutrition Market Breakdown, by Product Type
        • 11.1.3.2.1.1 Canada: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.1.3.2.2 Canada: Enteral Nutrition Market Breakdown, by Application
        • 11.1.3.2.3 Canada: Enteral Nutrition Market Breakdown, by Age Group
        • 11.1.3.2.4 Canada: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.1.3.3 Mexico: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.1.3.3.1 Mexico: Enteral Nutrition Market Breakdown, by Product Type
        • 11.1.3.3.1.1 Mexico: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.1.3.3.2 Mexico: Enteral Nutrition Market Breakdown, by Application
        • 11.1.3.3.3 Mexico: Enteral Nutrition Market Breakdown, by Age Group
        • 11.1.3.3.4 Mexico: Enteral Nutrition Market Breakdown, by Distribution Channel
  • 11.2 Europe
    • 11.2.1 Europe Enteral Nutrition Market Overview
    • 11.2.2 Europe: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
      • 11.2.2.1 Europe: Enteral Nutrition Market- Revenue and Forecast Analysis - by Product Type
        • 11.2.2.1.1 Europe: Enteral Nutrition Market- Revenue and Forecast Analysis - by Nasogastric
      • 11.2.2.2 Europe: Enteral Nutrition Market- Revenue and Forecast Analysis - by Application
      • 11.2.2.3 Europe: Enteral Nutrition Market- Revenue and Forecast Analysis - by Age Group
      • 11.2.2.4 Europe: Enteral Nutrition Market- Revenue and Forecast Analysis - by Distribution Channel
    • 11.2.3 Europe: Enteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 Germany: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.1.1 Germany: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.1.1.1 Germany: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.1.2 Germany: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.1.3 Germany: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.1.4 Germany: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.2 United Kingdom: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.2.1 United Kingdom: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.2.1.1 United Kingdom: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.2.2 United Kingdom: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.2.3 United Kingdom: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.2.4 United Kingdom: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.3 France: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.3.1 France: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.3.1.1 France: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.3.2 France: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.3.3 France: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.3.4 France: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.4 Italy: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.4.1 Italy: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.4.1.1 Italy: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.4.2 Italy: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.4.3 Italy: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.4.4 Italy: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.5 Spain: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.5.1 Spain: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.5.1.1 Spain: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.5.2 Spain: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.5.3 Spain: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.5.4 Spain: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.6 Czech Republic: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.6.1 Czech Republic: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.6.1.1 Czech Republic: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.6.2 Czech Republic: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.6.3 Czech Republic: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.6.4 Czech Republic: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.2.3.7 Rest of Europe: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.2.3.7.1 Rest of Europe: Enteral Nutrition Market Breakdown, by Product Type
        • 11.2.3.7.1.1 Rest of Europe: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.2.3.7.2 Rest of Europe: Enteral Nutrition Market Breakdown, by Application
        • 11.2.3.7.3 Rest of Europe: Enteral Nutrition Market Breakdown, by Age Group
        • 11.2.3.7.4 Rest of Europe: Enteral Nutrition Market Breakdown, by Distribution Channel
  • 11.3 Asia Pacific
    • 11.3.1 Asia Pacific Enteral Nutrition Market Overview
    • 11.3.2 Asia Pacific: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
      • 11.3.2.1 Asia Pacific: Enteral Nutrition Market- Revenue and Forecast Analysis - by Product Type
        • 11.3.2.1.1 Asia Pacific: Enteral Nutrition Market- Revenue and Forecast Analysis - by Nasogastric
      • 11.3.2.2 Asia Pacific: Enteral Nutrition Market- Revenue and Forecast Analysis - by Application
      • 11.3.2.3 Asia Pacific: Enteral Nutrition Market- Revenue and Forecast Analysis - by Age Group
      • 11.3.2.4 Asia Pacific: Enteral Nutrition Market- Revenue and Forecast Analysis - by Distribution Channel
    • 11.3.3 Asia Pacific: Enteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 China: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.1.1 China: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.1.1.1 China: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.1.2 China: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.1.3 China: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.1.4 China: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.3.3.2 Japan: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.2.1 Japan: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.2.1.1 Japan: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.2.2 Japan: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.2.3 Japan: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.2.4 Japan: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.3.3.3 India: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.3.1 India: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.3.1.1 India: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.3.2 India: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.3.3 India: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.3.4 India: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.3.3.4 South Korea: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.4.1 South Korea: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.4.1.1 South Korea: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.4.2 South Korea: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.4.3 South Korea: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.4.4 South Korea: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.3.3.5 Australia: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.5.1 Australia: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.5.1.1 Australia: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.5.2 Australia: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.5.3 Australia: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.5.4 Australia: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.3.3.6 Rest of APAC: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.3.3.6.1 Rest of APAC: Enteral Nutrition Market Breakdown, by Product Type
        • 11.3.3.6.1.1 Rest of APAC: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.3.3.6.2 Rest of APAC: Enteral Nutrition Market Breakdown, by Application
        • 11.3.3.6.3 Rest of APAC: Enteral Nutrition Market Breakdown, by Age Group
        • 11.3.3.6.4 Rest of APAC: Enteral Nutrition Market Breakdown, by Distribution Channel
  • 11.4 Middle East and Africa
    • 11.4.1 Middle East and Africa Enteral Nutrition Market Overview
    • 11.4.2 Middle East and Africa: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
      • 11.4.2.1 Middle East and Africa: Enteral Nutrition Market- Revenue and Forecast Analysis - by Product Type
        • 11.4.2.1.1 Middle East and Africa: Enteral Nutrition Market- Revenue and Forecast Analysis - by Nasogastric
      • 11.4.2.2 Middle East and Africa: Enteral Nutrition Market- Revenue and Forecast Analysis - by Application
      • 11.4.2.3 Middle East and Africa: Enteral Nutrition Market- Revenue and Forecast Analysis - by Age Group
      • 11.4.2.4 Middle East and Africa: Enteral Nutrition Market- Revenue and Forecast Analysis - by Distribution Channel
    • 11.4.3 Middle East and Africa: Enteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Saudi Arabia: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.4.3.1.1 Saudi Arabia: Enteral Nutrition Market Breakdown, by Product Type
        • 11.4.3.1.1.1 Saudi Arabia: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.4.3.1.2 Saudi Arabia: Enteral Nutrition Market Breakdown, by Application
        • 11.4.3.1.3 Saudi Arabia: Enteral Nutrition Market Breakdown, by Age Group
        • 11.4.3.1.4 Saudi Arabia: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.4.3.2 South Africa: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.4.3.2.1 South Africa: Enteral Nutrition Market Breakdown, by Product Type
        • 11.4.3.2.1.1 South Africa: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.4.3.2.2 South Africa: Enteral Nutrition Market Breakdown, by Application
        • 11.4.3.2.3 South Africa: Enteral Nutrition Market Breakdown, by Age Group
        • 11.4.3.2.4 South Africa: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.4.3.3 United Arab Emirates: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.4.3.3.1 United Arab Emirates: Enteral Nutrition Market Breakdown, by Product Type
        • 11.4.3.3.1.1 United Arab Emirates: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.4.3.3.2 United Arab Emirates: Enteral Nutrition Market Breakdown, by Application
        • 11.4.3.3.3 United Arab Emirates: Enteral Nutrition Market Breakdown, by Age Group
        • 11.4.3.3.4 United Arab Emirates: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.4.3.4 Rest of Middle East and Africa: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.4.3.4.1 Rest of Middle East and Africa: Enteral Nutrition Market Breakdown, by Product Type
        • 11.4.3.4.1.1 Rest of Middle East and Africa: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.4.3.4.2 Rest of Middle East and Africa: Enteral Nutrition Market Breakdown, by Application
        • 11.4.3.4.3 Rest of Middle East and Africa: Enteral Nutrition Market Breakdown, by Age Group
        • 11.4.3.4.4 Rest of Middle East and Africa: Enteral Nutrition Market Breakdown, by Distribution Channel
  • 11.5 South and Central America
    • 11.5.1 South and Central America Enteral Nutrition Market Overview
    • 11.5.2 South and Central America: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
      • 11.5.2.1 South and Central America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Product Type
        • 11.5.2.1.1 South and Central America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Nasogastric
      • 11.5.2.2 South and Central America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Application
      • 11.5.2.3 South and Central America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Age Group
      • 11.5.2.4 South and Central America: Enteral Nutrition Market- Revenue and Forecast Analysis - by Distribution Channel
    • 11.5.3 South and Central America: Enteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Brazil: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.5.3.1.1 Brazil: Enteral Nutrition Market Breakdown, by Product Type
        • 11.5.3.1.1.1 Brazil: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.5.3.1.2 Brazil: Enteral Nutrition Market Breakdown, by Application
        • 11.5.3.1.3 Brazil: Enteral Nutrition Market Breakdown, by Age Group
        • 11.5.3.1.4 Brazil: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.5.3.2 Argentina: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.5.3.2.1 Argentina: Enteral Nutrition Market Breakdown, by Product Type
        • 11.5.3.2.1.1 Argentina: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.5.3.2.2 Argentina: Enteral Nutrition Market Breakdown, by Application
        • 11.5.3.2.3 Argentina: Enteral Nutrition Market Breakdown, by Age Group
        • 11.5.3.2.4 Argentina: Enteral Nutrition Market Breakdown, by Distribution Channel
      • 11.5.3.3 Rest of South and Central America: Enteral Nutrition Market - Revenue, 2021 - 2031 (US$ Million)
        • 11.5.3.3.1 Rest of South and Central America: Enteral Nutrition Market Breakdown, by Product Type
        • 11.5.3.3.1.1 Rest of South and Central America: Enteral Nutrition Market Breakdown, by Nasogastric
        • 11.5.3.3.2 Rest of South and Central America: Enteral Nutrition Market Breakdown, by Application
        • 11.5.3.3.3 Rest of South and Central America: Enteral Nutrition Market Breakdown, by Age Group
        • 11.5.3.3.4 Rest of South and Central America: Enteral Nutrition Market Breakdown, by Distribution Channel

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Enteral Nutrition Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Nestle SA
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Danone SA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Abbott Laboratories
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Royal FrieslandCampina NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Fresenius SE & Co KGaA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 B Braun SE
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Reckitt Benckiser Group Plc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Kate Farms Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Dr Schar AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Fonterra Co-Operative Group Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Arla Foods amba
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Perrigo Co Plc
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Charing Cross Scientific AS
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Bexen Medical
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제